Sleeping Aids Market By Sleep Disorder 2021 | IndustryARC
  • 1-614-588-8538 (Ext: 101)
  • US Toll Free

Sleeping Aids Market
Sleeping Aids Market: By Sleep Disorder (Insomnia, Sleep Apnea, Restless Leg Syndrome, Narcolepsy, Sleep Walking) Product (Mattress & Pillow, Sleep Labs, Medication, Sleep Apena Devices) Medication (Prescription Based, OTC drugs, Herbal Drugs)-Forecast (2016-2021)
Report Code : HCR 0377
Updated Date: 08 September, 2016  

  • Report Description
  • Table of Contents
  • Customization Options
1. Sleeping Aids Market – Market Overview
2. Executive Summary
3. Market Landscape

   3.1. Market Share Analysis
   3.2. Comparative Analysis
   3.3. Product Benchmarking
   3.4. End User Profiling
   3.5. Top 5 Financials Analysis
4. Sleeping Aids Market– Market Forces
   4.1. Drivers
      4.1.1. Increasing usage of home sleep test for diagnosis of sleep apnea
      4.1.2. Increasing demand of sleeping pills due to stressful life
   4.2. Restraints
      4.2.1. Side effects of sleeping aids
   4.3. Opportunities
   4.4. Challenges
   4.5. Porter’s Five Forces Analysis
      4.5.1. Bargaining Power of Suppliers
      4.5.2. Bargaining Power of Buyers
      4.5.3. Threat of New Entrants
      4.5.4. Threat of Substitutes
      4.5.5. Degree of Competition
5. Sleeping Aids Market– Strategic Analysis
   5.1. Value Chain Analysis
   5.2. Pricing Analysis
   5.3. Opportunities Analysis
   5.4. Product/Market Life Cycle Analysis
   5.5. Suppliers and Distributors
6. Sleeping Aids Market, By Sleeping Disorders
   6.1. Insomnia
   6.2. Sleep Apnea
   6.3. Restless Leg Syndrome
   6.4. Narcolepsy
   6.5. Sleep Walking
   6.6. Others
7. Sleeping Aids Market, By Product
   7.1. Mattress & Pillow
   7.2. Sleep Labs
   7.3. Medication
   7.4. Sleep Apena Devices
   7.5. Others
8. Sleeping Aids Market, By Medication
   8.1. Prescription based Drugs
   8.2. OTC Drugs
   8.3. Herbal medication
9. Sleeping Aids Market, By Geography
   9.1. Europe
      9.1.1. Germany
      9.1.2. France
      9.1.3. Italy
      9.1.4. Spain
      9.1.5. Russia
      9.1.6. U.K.
      9.1.7. Rest of Europe
   9.2. Asia Pacific
      9.2.1. China
      9.2.2. India
      9.2.3. Japan
      9.2.4. South Korea
      9.2.5. Rest of Asia-Pacific
   9.3. North America
      9.3.1. U.S.
      9.3.2. Canada
      9.3.3. Mexico
   9.4. Rest of the World (RoW)
      9.4.1. Brazil
      9.4.2. Rest of RoW
10. Sleeping Aids Market – Market Entropy
   10.1. Expansion
   10.2. Technological Developments
   10.3. Merger & Acquisitions, and Joint Ventures
   10.4. Supply- Contract
11. Company Profiles (Overview, Financials, SWOT Analysis, Developments, Product Portfolio)
   11.1. Sanofi
   11.2. Merck & Co.
   11.3. Pfizer
   11.4. Koninklijke Philips N.V. (Philips)
   11.5. GlaxoSmithKline Plc
   11.6. Takeda Pharmaceutical Company Limited
   11.7. Care Fusion Corporation
   11.8. Teva Pharmaceutical Industries Ltd.
   11.9. SleepMed, Inc
   11.10. Natus Medical manufactures
   11.11. DeVilbiss Healthcare LLC
   11.12. Compumedics Limited.
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"
12. Appendix

   12.1. Abbreviations
   12.2. Sources
   12.3. Research Methodology
   12.4. Bibliography
   12.5. Compilation of Expert Insights
   12.6. Disclaimer
Sleep aids are pills and medical devices that enable a person suffering from sleep disorder to fall asleep. Sleep aids consist of various products such as medications, sleep laboratories, sleep apnea devices, and mattresses & pillows. Higher stress levels amongst people in developed nations and fast changing life styles in the developing nations are expected to remain key growth drivers for the sleeping aid products during the period of study and are also expected to intensify as population with higher stress levels in the near future.

 Sleeping Aids Market

Geographically North America dominated sleeping aids market driven by higher stress levels amongst citizens, higher awareness about such products and higher spending by the citizens towards healthcare expenditure. North America was followed by Europe and Asia-Pacific as second and third largest market for sleeping aids market. Asia Pacific is projected to have fastest growth, owing to rapidly increasing people living under stress due to changing lifestyle, increased spending, and increasing awareness amongst population in developing nations such as China, and India in this region.

This report identifies the global sleeping aids market size in for the year 2014-2016, and forecast of the same for year 2021. It also highlights the market drivers, restraints, growth indicators, challenges, and other key aspects with respect to global sleeping aids market.

This report segments global sleeping aids market on the basis of sleeping disorders, products and medication and regional market as follows:

  • Sleeping Aids Market research report is classified on the basis of sleeping disorders. Some of the major sleeping disorders covered in this report are as follows: Insomnia, Sleep Apnea, Restless Leg Syndrome, Narcolepsy, Sleep Walking and others
  • Sleeping Aids Market research report is classified on the basis of products. Some of the major products covered in this report are as follows: Mattress & Pillow, Sleep Labs, Medication, Sleep Apena Devices
  • Sleeping Aids Market research report is classified on the basis of medication. Some of the major medication covered in this report are as follows: Prescription Based, OTC drugs, and Herbal Drugs
  • This report has been further segmented into major regions, which includes detailed analysis of each region such as: North America, Europe, Asia-Pacific (APAC), and Rest of the World (RoW) covering all the major country level markets in each of the region

This report identifies all the major companies operating in the sleeping aids market. Some of the major companies’ profiles in detail are as follows:
  • Koninklijke Philips N.V. (Philips)
  • GlaxoSmithKline Plc
  • Takeda Pharmaceutical Company Limited
  • Care Fusion Corporation
  • Teva Pharmaceutical Industries Ltd.
Please select Licence
Single User Licence:
US $4250
Corporate User Licence:
US $6250
Related Reports